Fidelity Investments’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,061,996
| Closed | -$72.3M | – | 5809 |
|
|
2023
Q4 | $72.3M | Buy |
3,061,996
+1,493,048
| +95% | +$35.3M | 0.01% | 1144 |
|
|
2023
Q3 | $23.4M | Buy |
1,568,948
+1,557,462
| +13,560% | +$23.2M | ﹤0.01% | 1531 |
|
|
2023
Q2 | $126K | Buy |
11,486
+232
| +2% | +$2.54K | ﹤0.01% | 3084 |
|
|
2023
Q1 | $98.1K | Buy |
11,254
+14
| +0.1% | +$122 | ﹤0.01% | 3213 |
|
|
2022
Q4 | $70.5K | Buy |
11,240
+25
| +0.2% | +$157 | ﹤0.01% | 3327 |
|
|
2022
Q3 | $39K | Hold |
11,215
| – | – | ﹤0.01% | 3577 |
|
|
2022
Q2 | $33K | Sell |
11,215
-60
| -0.5% | -$177 | ﹤0.01% | 3719 |
|
|
2022
Q1 | $35K | Buy |
+11,275
| New | +$35K | ﹤0.01% | 3810 |
|
|
2021
Q2 | – | Sell |
-239
| Closed | -$1K | – | 5037 |
|
|
2021
Q1 | $1K | Buy |
+239
| New | +$1K | ﹤0.01% | 3908 |
|
|
2020
Q2 | – | Sell |
-1
| Closed | – | – | 4273 |
|
|
2020
Q1 | $0 | Sell |
1
-38
| -97% | – | ﹤0.01% | 4361 |
|
|
2019
Q4 | $0 | Sell |
39
-300
| -88% | – | ﹤0.01% | 4357 |
|
|
2019
Q3 | $2K | Buy |
339
+300
| +769% | +$1.77K | ﹤0.01% | 3591 |
|
|
2019
Q2 | $0 | Sell |
39
-122,700
| -100% | – | ﹤0.01% | 4278 |
|
|
2019
Q1 | $1.63M | Sell |
122,739
-424,789
| -78% | -$5.64M | ﹤0.01% | 2346 |
|
|
2018
Q4 | $4.31M | Sell |
547,528
-1,143,897
| -68% | -$9M | ﹤0.01% | 2084 |
|
|
2018
Q3 | $18.7M | Sell |
1,691,425
-724,412
| -30% | -$8.03M | ﹤0.01% | 1704 |
|
|
2018
Q2 | $32.4M | Sell |
2,415,837
-3,168,280
| -57% | -$42.5M | ﹤0.01% | 1492 |
|
|
2018
Q1 | $72.5M | Buy |
5,584,117
+3,256,597
| +140% | +$42.3M | 0.01% | 1124 |
|
|
2017
Q4 | $21.4M | Hold |
2,327,520
| – | – | ﹤0.01% | 1692 |
|
|
2017
Q3 | $18.8M | Buy |
+2,327,520
| New | +$18.8M | ﹤0.01% | 1716 |
|